Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioharvest Sciences (BHST) Other Accumulated Expenses (2024 - 2025)

Bioharvest Sciences has reported Other Accumulated Expenses over the past 2 years, most recently at $452000.0 for Q4 2025.

  • For Q4 2025, Other Accumulated Expenses fell 60.35% year-over-year to $452000.0; the TTM value through Dec 2025 reached $452000.0, down 60.35%, while the annual FY2025 figure was $452000.0, 60.35% down from the prior year.
  • Other Accumulated Expenses was $452000.0 for Q4 2025 at Bioharvest Sciences, down from $1.1 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $1.1 million in Q4 2024 and bottomed at $452000.0 in Q4 2025.